Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PYXS | VRCA | PYPD | ||
| Company | Pyxis Oncology Inc | Verrica Pharmaceuticals Inc | Polypid Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.6000 | 6.09 | 4.90 | ||
| High | 1.7850 | 6.49 | 4.95 | ||
| Low | 1.6000 | 5.93 | 4.68 | ||
| Latest | 1.7300 | 6.06 | 4.77 | ||
| Change | +0.1000 | +0.04 | -0.07 | ||
| % Change | +6.13% | +0.66% | -1.45% | ||
| Volume | 430,100 | 25,800 | 238,700 | ||
| 20-Day Average Volume | 730,855 | 86,690 | 106,835 | ||
| Previous Close | 1.6300 | 6.02 | 4.84 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.0810 | 6.70 | 4.58 | ||
| 20-Day Raw Stochastic | 11.74% | 19.21% | 57.84% | ||
| 20-Day Relative Strength | 45.99 | 47.10 | 55.41 | ||
| Weighted Alpha | +20.19 | -49.93 | +64.22 | ||
| Today's Opinion | 40% Sell | 8% Sell | 100% Buy | ||
| Previous Opinion | 56% Sell | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 40% Sell | 40% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.42% since 05/19/26 | +8.41% since 05/19/26 | +0.21% since 05/19/26 | ||
| Low | 1.5717 on 05/26/26 | 5.48 on 05/22/26 | 4.68 on 05/27/26 | ||
| High | 2.0900 on 05/20/26 | 6.49 on 05/27/26 | 5.20 on 05/26/26 | ||
| 1-Month | |||||
| %Chg | -1.70% since 04/27/26 | -11.21% since 04/27/26 | +4.15% since 04/27/26 | ||
| Low | 1.5717 on 05/26/26 | 5.48 on 05/22/26 | 4.18 on 05/13/26 | ||
| High | 2.9200 on 05/11/26 | 8.50 on 05/06/26 | 5.20 on 05/26/26 | ||
| 3-Month | |||||
| %Chg | +17.69% since 02/27/26 | +10.79% since 02/27/26 | +12.24% since 02/27/26 | ||
| Low | 1.2600 on 03/30/26 | 4.24 on 03/24/26 | 4.01 on 03/02/26 | ||
| High | 2.9200 on 05/11/26 | 8.50 on 05/06/26 | 5.20 on 05/26/26 | ||
| 6-Month | |||||
| %Chg | -67.23% since 11/26/25 | -9.69% since 11/26/25 | +25.53% since 11/26/25 | ||
| Low | 1.0300 on 12/26/25 | 4.24 on 03/24/26 | 3.72 on 12/02/25 | ||
| High | 5.4200 on 11/28/25 | 9.82 on 11/28/25 | 5.20 on 05/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 103,269 | 103,418 | 92,362 | ||
| Shares Outstanding, K | 63,355 | 17,179 | 19,083 | ||
| Annual Sales | 13,860,000 | 35,580,000 | 0 | ||
| Annual Net Income | -79,620,000 | -17,890,000 | -34,170,000 | ||
| Last Quarter Sales | 11,040,000 | 5,020,000 | 0 | ||
| Last Quarter Net Income | -18,110,000 | -9,680,000 | -7,730,000 | ||
| 60-Month Beta | 1.43 | 1.54 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 05/14/26 | -0.41 on 05/12/26 | -0.35 on 05/13/26 | ||
| Earnings Date | 08/13/26 | 08/11/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||